Cointime

Download App
iOS & Android

Adaptive Biotechnologies

company
Funding Round
Post-IPO Debt
Money Raised
$ 125M
Propotion
-
Post Valuation
-

Current Round Investors

Investor Name Invest Money Lead Investor Propotion
OrbiMed - Yes - Detail

Historical Financing

Announced Date Round Money Raised Investors
Mar 24, 2022 Post-IPO Equity 0 ARK Investment Management Detail
Apr 15, 2014 Series D $ 100M Viking Global Investors Detail
Mar 5, 2018 Secondary Market 0 EquityZen Detail
Jul 14, 2020 Post-IPO Equity 0 Detail
Sep 13, 2013 Grant $ 2.50M Detail
May 7, 2015 Series F $ 195M Matrix Capital Management,Rock Springs Capital,etc. Detail
Apr 7, 2014 Series C $ 5M Viking Global Investors Detail
Jan 7, 2015 Series E $ 94M Detail
Jun 10, 2011 Series B $ 5.80M Detail
Mar 24, 2010 Series A $ 4.55M Detail
Jun 26, 2019 IPO $ 300M Detail